查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014868

左心耳封堵器市場：依器械類型、手術類型、支付方式、材料類型、最終用戶和分銷管道分類－2026-2032年全球預測

Left Atrial Appendage Closure Device Market by Device Type, Procedure Type, Payment Mode, Material Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年左心耳封堵器市值為 10.1 億美元，預計到 2026 年將成長至 11.7 億美元，複合年成長率為 16.68%，到 2032 年將達到 29.7 億美元。

主要市場統計數據
基準年 2025 10.1億美元
預計年份：2026年 11.7億美元
預測年份 2032 29.7億美元
複合年成長率 (%) 16.68%

簡要概述了近年來在左心耳封堵裝置的引入和使用方面取得的臨床進展、程序改進和戰略考慮。

對於部分不適合長期口服抗凝血治療的心房顫動患者，左心耳封堵術已成為降低中風風險的重要治療選擇。近年來，封堵器設計、輸送系統以及術前術後影像技術的不斷改進，大大改變了臨床工作流程，為安全有效地進行此類手術提供了更廣闊的環境。隨著臨床醫生不斷最佳化患者選擇標準，以及從業人員經驗的積累，討論的重點已從封堵器的療效擴展到其安全性、植入的便捷性以及對術後護理和醫保報銷的影響。

設備設計、影像和醫療保健服務的創新如何重新定義手術流程、臨床應用和競爭優勢。

左心耳封堵裝置的格局正經歷著從裝置工程到醫療服務模式等多方面的變化。隨著裝置的不斷改進，對不同解剖結構的適應性和操作便利性成為優先考慮的因素，新的裝置形狀降低了手術複雜性，並縮短了術者的訓練時間。同時，影像技術和手術規劃工具的日趨成熟，使得術前評估和術中指導更加精準，從而降低了併發症發生率，提高了手術成功率。

分析到 2025 年貿易政策的影響，以及由此導致的供應鏈韌性、採購來源多元化和採購談判趨勢的變化。

到2025年，關稅調整和貿易政策變化已對醫療設備製造商及其客戶（醫療系統營運商）的供應鏈、採購選擇和成本結構產生了累積影響。進口零件和成品關稅的提高推高了依賴跨境採購的企業的基準成本，促使許多企業重新評估其供應商組合，協商長期契約，並尋找關鍵材料的替代來源。因此，製造商正在加速採用雙重採購策略，並探索近岸外包和部分在地化生產，以降低關稅波動帶來的風險並減少前置作業時間的不確定性。

從細分市場的觀點，將醫療設備、治療過程、支付方趨勢、材料、最終用戶概況和分銷策略的變化與市場准入要求聯繫起來。

清晰理解細分市場中的細微差別對於制定能夠反映真實臨床和購買行為的產品策略和商業計劃至關重要。器械類型細分區分了基於縫合線的Lariat系統和Watchman系列閉塞裝置。在Watchman系列中，Watchman 2和Watchman Flx兩種型號展現出不同的輸送特性和手術流程，進而影響臨床醫師的偏好和訓練需求。手術類型細分區分了利用微創流程和門診優勢的經經皮路，以及需要更多資源且通常需要在手術室進行的外科手術。

區域趨勢和市場進入重點反映了美洲、歐洲、中東和非洲以及亞太地區在監管、報銷和臨床實踐方面的差異。

區域趨勢持續對美洲、歐洲、中東和非洲以及亞太地區的監管時間表、報銷政策和臨床實踐規範產生重大影響。在美洲，成熟的介入性心臟病中心和雄厚的資本投資能力支持快速部署迭代式器械平台，並建立上市後註冊登記系統，從而增強臨床醫生的信心。公立和私立醫療體系的支付環境存在差異，影響醫院對新器械部署和培訓投資的優先順序。歐洲部分地區以及中東和非洲的過渡性監管情勢和集中報銷談判日益強調系統性的醫療技術評估和療效比較數據，促使製造商相應地調整其循證策略。

臨床差異化、實證策略和綜合商業性支援決定了左心耳封堵器供應商的競爭優勢。

左心耳封堵術的競爭優勢取決於臨床差異化、循證醫學證據的累積以及為外科醫生和醫療機構提供全面支持的能力。成熟的醫療設備製造商透過不斷迭代的平台升級，通常利用豐富的上市後數據和廣泛的培訓網路來維持臨床醫生的支持。而新參與企業則往往憑藉其獨特的價值提案展開競爭，例如微型化的輸送系統、簡化的手術流程或具有更易於植入或特定解剖學優勢的替代材料結構。

可操作的策略重點，旨在加強臨床證據、確保供應彈性、最佳化商業化管道，並加速支付方和醫療服務提供者的採用。

產業領導企業應推動一系列切實可行的舉措，以確保臨床信心、穩定供應鏈並加速在各種醫療機構中的應用。首先，應優先進行臨床證據項目，這些項目不僅要關注手術的療效，還要關注其相對安全性、長期療效和以患者為中心的治療結果。這將有助於與保險公司進行對話，並鼓勵醫療機構將相關技術納入處方集。其次，應重新設計供應鏈結構，引入雙重採購、區域組裝和戰略緩衝庫存，以降低關稅造成的成本衝擊和物流中斷風險。

我們採用嚴格的混合方法，結合專家訪談、臨床文獻整合和交叉檢驗的供應鏈分析，得出了實用見解。

本執行摘要的研究結合了結構化的初步研究和嚴謹的二次分析，以確保得出平衡且可靠的檢驗。初步研究包括對介入性心臟病專家、電生理學家、醫院採購經理和行業高管進行深度訪談，以了解操作實踐、臨床偏好和採購決定因素。這些定性資訊與同行評審的臨床文獻、監管決策文件和公開的程序指南進行交叉比對，以確定安全性和有效性趨勢，並揭示器械改進如何影響手術流程。

從創新、經濟壓力和策略協調的觀點全面分析左心耳封堵術的普及和價值實現所需的要素。

總之，左心耳封堵器材領域呈現顯著的臨床創新、手術方式轉變與商業發展趨勢。器械輸送和材料成分的改進，以及影像學和術前術後管理的進步，正在降低手術複雜性，並擴大此類治療方法的安全應用範圍。同時，關稅和報銷預期等經濟因素帶​​來的成本壓力及其複雜影響，要求製造商和醫療機構在實證醫學證據、採購方案和風險分擔機制方面開展更緊密的合作。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 左心耳封堵器市場：依器材類型分類

  • Lariat
  • 守望者
    • 守望者2
    • 守望者 Flx

第9章 左心耳封堵器市場（依治療類型分類）

  • 經皮
  • 外科

第10章：左心耳封堵器市場：依支付方式分類

  • 私人保險
  • 公共保險

第11章：左心耳封堵器市場：依材料類型分類

  • 鎳鈦諾
    • 鎳鈦合金
    • 超彈性鎳鈦諾
  • 聚合物塗層

第12章 左心耳封堵器市場：依最終用戶分類

  • 心臟病中心
  • 診所
    • 門診治療
    • 專科診所
  • 醫院
    • 二級醫療機構
    • 三級醫療機構

第13章：左心耳封堵器市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上管道

第14章 左心耳封堵器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 左心耳封堵器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 左心耳封堵器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國左心耳封堵器市場

第18章：中國左心耳封堵器市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acutus Medical, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corp
  • Johnson & Johnson
  • LifeTech Scientific Corporation
  • MicroPort Scientific Corporation
  • SentreHEART, Inc.
  • Shenzhen Lepu Medical Technology Co., Ltd.
Product Code: MRR-43470FC6085A

The Left Atrial Appendage Closure Device Market was valued at USD 1.01 billion in 2025 and is projected to grow to USD 1.17 billion in 2026, with a CAGR of 16.68%, reaching USD 2.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.01 billion
Estimated Year [2026] USD 1.17 billion
Forecast Year [2032] USD 2.97 billion
CAGR (%) 16.68%

A concise orientation to recent clinical advances, procedural refinements, and strategic considerations shaping left atrial appendage closure device adoption and use

Left atrial appendage closure devices have emerged as a pivotal therapeutic option for reducing stroke risk in selected patients with atrial fibrillation who are not ideal candidates for long-term oral anticoagulation. Over recent years, iterative improvements in device design, delivery systems, and peri-procedural imaging have transformed clinical workflows and broadened the settings in which these procedures can be safely and effectively performed. As clinicians refine patient selection and operators gain experience, the discussion has shifted beyond device efficacy toward comparative safety profiles, ease of implantation, and downstream implications for post-procedure care and reimbursement.

This executive summary distills contemporary market dynamics, clinical and regulatory inflection points, and operational considerations that matter to device manufacturers, healthcare providers, and payers. It contextualizes device innovations alongside procedural trends and payment environments, while emphasizing the interplay between material science advances and real-world adoption patterns. The purpose is to deliver a concise yet comprehensive orientation for decision-makers seeking to align product development, commercial strategy, and clinical engagement in a rapidly evolving landscape.

How innovations in device design, imaging, and care delivery are jointly redefining procedural pathways, clinical adoption, and competitive differentiation

The landscape for left atrial appendage closure devices is being reshaped by several transformative shifts that extend from device engineering to care delivery models. Advances in device iterations have prioritized deliverability and conformability to diverse anatomies, with newer profiles reducing procedural complexity and shortening learning curves for operators. Simultaneously, imaging modalities and procedural planning tools have matured, enabling more precise pre-procedural assessment and intra-procedural guidance that together reduce complication rates and improve procedural success.

Concurrently, care pathways are evolving as percutaneous approaches gain traction relative to surgical options in many centers, supported by streamlined peri-procedural protocols and faster patient throughput. Market access dynamics are also changing; payers and health systems increasingly demand robust comparative safety and economic value evidence in order to justify adoption at scale. Lastly, competitive differentiation is migrating from single-product attributes toward integrated solutions that combine a clear clinical value proposition, training and service offerings, and flexible commercial models that accommodate diverse hospital procurement practices.

Analysis of trade policy ramifications through 2025 and the consequent shifts toward supply chain resilience, sourcing diversification, and procurement negotiation dynamics

Tariff shifts and trade policy adjustments enacted through 2025 have had a cumulative effect on supply chains, procurement choices, and cost structures for medical device manufacturers and their health system customers. Increased duties on imported components and finished devices have raised the baseline cost for firms that rely on cross-border sourcing, prompting many to reassess supplier portfolios, negotiate long-term contracts, and seek alternative origins for critical inputs. As a result, manufacturers are accelerating dual-sourcing strategies and exploring nearshoring or partial localization of production to mitigate exposure to tariff volatility and reduce lead-time uncertainty.

The indirect consequences for hospitals and clinics have been material even when tariffs do not apply directly to finished devices. Procurement teams face greater pricing variability and elongated negotiation cycles as suppliers pass through incremental costs. In response, health systems are tightening capital expenditure approvals and emphasizing total cost of care analyses that account for device-related consumables, procedural time, and potential downstream savings from avoided adverse events. Regulatory compliance and customs complexity have also increased administrative burdens, diverting resources toward logistics and quality assurance. Overall, the tariff environment is fostering a strategic emphasis on supply chain resilience, diversified sourcing, and closer collaboration between manufacturers and large purchasing entities to stabilize availability and manage cost pressures.

Segment-level perspectives linking device variants, procedural pathways, payer dynamics, materials, end-user profiles, and distribution strategies to commercialization imperatives

A clear understanding of segmentation nuances is essential for designing product strategies and commercial plans that reflect real-world clinical and purchasing behaviors. Device type segmentation distinguishes between suture-based Lariat systems and occlusion devices in the Watchman family, where Watchman 2 and Watchman Flx variants exhibit differing deliverability profiles and procedural workflows that influence clinician preferences and training requirements. Procedure type segmentation separates percutaneous approaches, which benefit from minimally invasive workflows and outpatient pathways, from surgical alternatives that are more resource intensive and typically confined to operating theater environments.

Payment mode segmentation drives commercial engagement priorities: private insurance settings often respond to evidence of comparative clinical value and negotiated pricing, whereas public insurance environments emphasize standardized reimbursement codes and population-level budget impact. Material type segmentation differentiates Nitinol-based devices from those using polymer coatings; within Nitinol, distinctions between nickel-titanium alloy formulations and superelastic Nitinol variants have implications for device conformability, fatigue resistance, and long-term durability. End-user segmentation captures divergent needs across cardiology centers, clinics, and hospitals, with clinics further differentiated into ambulatory care and specialty clinics and hospitals split between secondary and tertiary institutions; these distinctions affect procurement cycles, training expectations, and procedural volumes. Distribution channel segmentation spans direct sales models, distributors, and online channels, each requiring tailored commercial tactics and support infrastructures to ensure clinical adoption and inventory reliability. Collectively, these segmentation lenses inform product portfolio decisions, target account selection, and commercialization investments that align with clinical realities and purchaser behaviors.

Regional dynamics and market-entry priorities that reflect regulatory, reimbursement, and clinical practice variations across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics continue to exert strong influence on regulatory timelines, reimbursement policies, and clinical practice norms across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, well-established interventional cardiology centers and capital investment capability support rapid adoption of iterative device platforms and the conduct of post-market registries that shape clinician confidence. Payment landscapes vary between private and public systems, which in turn affects how hospitals prioritize new device adoption and training investments. Transitional regulatory pathways and centralized reimbursement negotiations in parts of Europe, Middle East & Africa favor systematic health technology assessment and comparative-effectiveness data, leading manufacturers to adapt evidence-generation strategies accordingly.

Across Asia-Pacific, a combination of high procedure volumes in select markets and growing local manufacturing capacity is driving a bifurcated market trajectory: leading academic centers adopt premium differentiated platforms while emerging centers often favor cost-effective alternatives and streamlined training solutions. Cross-border trade flows, regional distributor networks, and differing clinical guidelines mean that market entry strategies must be regionally customized. In all regions, collaboration with key opinion leaders, investment in local training programs, and alignment with regional reimbursement frameworks remain critical levers for accelerating safe and sustained adoption of closure technologies.

How clinical differentiation, evidence strategies, and integrated commercial support define competitive advantage among left atrial appendage closure device providers

Competitive positioning in left atrial appendage closure hinges on clinical differentiation, evidence generation, and the ability to deliver comprehensive surgeon and institutional support. Established device manufacturers that offer iterative platform upgrades typically leverage substantial post-market data and broad training networks to maintain clinician loyalty. Newer entrants often compete on niche value propositions such as reduced profile delivery systems, simplified procedural steps, or alternative material constructs that promise easier implantation or specific anatomical advantages.

Beyond core device attributes, successful companies are those that integrate clinical education, case proctoring, and service-level agreements into their commercial models. Strategic partnerships with imaging providers, catheter manufacturers, and specialized distributors can accelerate market penetration by offering bundled solutions that simplify hospital procurement. Additionally, firms that proactively engage with payers and health technology assessment bodies to demonstrate comparative safety and value tend to navigate reimbursement hurdles more effectively. Scalability of manufacturing and robustness of supply chain operations also distinguish market leaders, particularly in an environment where tariff sensitivity and sourcing flexibility influence continuity of supply and price stability.

Actionable strategic priorities to strengthen clinical evidence, secure supply resilience, optimize commercialization channels, and accelerate adoption across payer and provider environments

Industry leaders should pursue a set of pragmatic actions to secure clinical trust, stabilize supply economics, and accelerate adoption across diverse care settings. First, prioritize clinical evidence programs that address not only procedural efficacy but also comparative safety, long-term durability, and patient-centered outcomes; this will enhance payer conversations and support inclusion in institutional formularies. Second, redesign supply chain architectures to include dual sourcing, regional assembly, and strategic buffer inventories that reduce exposure to tariff-driven cost shocks and logistical disruptions.

Third, tailor commercialization models to distribution realities by balancing direct sales relationships with selective distributor partnerships and exploring digital channels for order management and clinical support. Fourth, invest in comprehensive training ecosystems-combining simulator-based learning, proctoring, and remote mentorship-to shorten learning curves for operators adopting Watchman 2, Watchman Flx, or suture-based systems. Fifth, engage earlier with public and private payers to align evidence generation with reimbursement criteria, thereby smoothing market access in both private insurance and public insurance environments. Finally, pursue material innovations that optimize device conformability and durability-leveraging advances in superelastic Nitinol formulations and polymer coatings-while transparently documenting safety and performance to clinicians and procurement stakeholders.

A rigorous mixed-methods research approach combining expert interviews, clinical literature synthesis, and cross-validated supply chain analysis to produce actionable insights

The research underpinning this executive summary combined structured primary inquiry with rigorous secondary analysis to ensure a balanced and validated set of findings. Primary research included in-depth interviews with interventional cardiologists, electrophysiologists, hospital procurement leaders, and industry executives to surface operational realities, clinical preferences, and purchasing drivers. These qualitative inputs were triangulated with peer-reviewed clinical literature, regulatory decision documents, and publicly available procedural guidance to confirm safety and efficacy trends and to map how device iterations alter procedural workflows.

Secondary research efforts focused on technology trend analysis, materials science developments, and supply chain considerations, with attention to how tariff changes and regional trade patterns affect manufacturing and distribution. Data synthesis relied on cross-validation techniques to reconcile differing stakeholder perspectives and to identify consensus areas for strategic action. Quality assurance steps included multiple rounds of expert review and verification of technical descriptions by clinicians familiar with Watchman family devices and suture-based closure systems. The methodology recognizes inherent limitations related to evolving regulatory landscapes and emergent clinical data, and it emphasizes the need for continuous evidence updates as new real-world outcomes and payer decisions become available.

Summative perspective on innovation, economic pressures, and strategic alignment needed to sustain adoption and value delivery in left atrial appendage closure therapies

In conclusion, the left atrial appendage closure device environment is characterized by meaningful clinical innovation, shifting procedural preferences, and increasing commercial sophistication. Device-level improvements in deliverability and material composition, paired with advances in imaging and peri-procedural management, have reduced procedural complexity and expanded the contexts in which these therapies can be delivered safely. At the same time, economic headwinds such as tariff-induced cost pressures and nuanced reimbursement expectations require manufacturers and providers to collaborate more closely on evidence generation, procurement solutions, and risk-sharing arrangements.

Looking ahead, successful stakeholders will be those who align robust clinical data with pragmatic supply chain strategies and adaptive commercialization models that reflect segmentation realities-from device variants and procedural types to payment modes, end-user profiles, and distribution channels. By focusing on resilient operations, targeted evidence investments, and clinician-centric support, device manufacturers and provider organizations can accelerate meaningful adoption while managing cost and access pressures in diverse regional contexts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Left Atrial Appendage Closure Device Market, by Device Type

  • 8.1. Lariat
  • 8.2. Watchman
    • 8.2.1. Watchman 2
    • 8.2.2. Watchman Flx

9. Left Atrial Appendage Closure Device Market, by Procedure Type

  • 9.1. Percutaneous
  • 9.2. Surgical

10. Left Atrial Appendage Closure Device Market, by Payment Mode

  • 10.1. Private Insurance
  • 10.2. Public Insurance

11. Left Atrial Appendage Closure Device Market, by Material Type

  • 11.1. Nitinol
    • 11.1.1. Nickel Titanium Alloy
    • 11.1.2. Superelastic Nitinol
  • 11.2. Polymer Coated

12. Left Atrial Appendage Closure Device Market, by End User

  • 12.1. Cardiology Centers
  • 12.2. Clinics
    • 12.2.1. Ambulatory Care
    • 12.2.2. Specialty Clinics
  • 12.3. Hospitals
    • 12.3.1. Secondary Hospitals
    • 12.3.2. Tertiary Hospitals

13. Left Atrial Appendage Closure Device Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor
  • 13.3. Online Channels

14. Left Atrial Appendage Closure Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Left Atrial Appendage Closure Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Left Atrial Appendage Closure Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Left Atrial Appendage Closure Device Market

18. China Left Atrial Appendage Closure Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Acutus Medical, Inc.
  • 19.7. AtriCure, Inc.
  • 19.8. Boston Scientific Corporation
  • 19.9. Edwards Lifesciences Corp
  • 19.10. Johnson & Johnson
  • 19.11. LifeTech Scientific Corporation
  • 19.12. MicroPort Scientific Corporation
  • 19.13. SentreHEART, Inc.
  • 19.14. Shenzhen Lepu Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY LARIAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY LARIAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY LARIAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN 2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN 2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN 2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN FLX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN FLX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN FLX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PUBLIC INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PUBLIC INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PUBLIC INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NICKEL TITANIUM ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NICKEL TITANIUM ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NICKEL TITANIUM ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SUPERELASTIC NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SUPERELASTIC NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SUPERELASTIC NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SECONDARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SECONDARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY TERTIARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY TERTIARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 182. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 186. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 215. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 219. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 226. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 230. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY WATCHMAN, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY NITINOL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA LEFT ATRIAL APPENDAGE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)